Balicatib is a potent and selective inhibitor of cathepsin K ,with 10-100 fold more potent in cell-based enzyme occupancy assays than against cathepsin B, L, and S.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Cysteine Protease ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Z-FA-FMK | ✔ | 99%+ | |||||||||||||||||
Leupeptin hemisulfate | ✔ | 97% | |||||||||||||||||
PMSF | ✔ | 95% | |||||||||||||||||
PD 151746 |
+
μ-Calpain, IC50: 260 nM m-calpain, IC50: 5.33 μM |
98% | |||||||||||||||||
Odanacatib |
++++
Cathepsin K (rabbit), IC50: 1 nM Cathepsin K (human), IC50: 0.2 nM |
99%+ | |||||||||||||||||
E-64 |
+++
Cysteine protease, IC50: 9 nM |
99%+ | |||||||||||||||||
E 64c | ✔ | 95% | |||||||||||||||||
E-64d | ✔ | 99%+ | |||||||||||||||||
MG-101 | ✔ | 98%+ | |||||||||||||||||
Calpeptin |
++
Calpain II (porcine kidney), ID50: 40 nM Calpain I (porcine erythrocytes), ID50: 52 nM |
98%+ | |||||||||||||||||
Cathepsin inhibitor 1 |
+++
Cathepsin L2, pIC50: 5.5 Cathepsin L, pIC50: 7.9 |
98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Cathepsin K is a member of the papain family of cysteine proteases which is associated with osteopetrosis, impaired resorption of bone matrix, impaired processing of thyroglobulin and reduced release of thyroid hormone. Balicatib is a very potent and selective inhibitor of human cathepsin K, with a Ki value of 0.7 nM. 140 postmenopausal women administered of AAE-581 once a day orally (10-50 mg per day) showed successful reduced bone resorption and improved bone formation[3]. Balicatib treatment for 18 months in female cynomolgus monkeys (orally twice daily by nasogastric intubation, 10/30/50 mg/kg/day) partially prevented ovariectomy-induced changes in bone mass and inhibited cancellous bone turnover[4]. |
作用机制 | Balicatib targets to lysosomes by conjugating with poly(ethylene glycol) polymers. |
Dose | Cynomolgus monkey: 3 mg/kg - 50 mg/kg[3] (p.o.) Rat: 10 mg/kg[2] (p.o.) |
Administration | p.o. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.43mL 0.49mL 0.24mL |
12.15mL 2.43mL 1.21mL |
24.30mL 4.86mL 2.43mL |
CAS号 | 354813-19-7 |
分子式 | C23H33N5O2 |
分子量 | 411.54 |
别名 | AAE581 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 80 mg/mL(194.39 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |